Pfizer is currently being accepted for the Grants for Pediatric Pneumococcal Surveillance Studies 2026. Interested applicants are encouraged to click here to learn more about this opportunity and apply for it.
About Pfizer Grants for Pediatric Pneumococcal Surveillance Studies
The Pfizer Research Grant supports studies addressing critical knowledge gaps in pediatric pneumococcal disease in Saudi Arabia. Despite over 20 years of pneumococcal conjugate vaccine (PCV) use, gaps remain in serotype distribution, disease burden, and antimicrobial resistance.
Benefits of Pfizer Grants for Pediatric Pneumococcal Surveillance Studies
- Individual projects requesting up to 400,000 USD will be considered. Projects costing higher than this may be considered on a case-by-case basis. The maximum project length is 3 years.
- Award amounts include direct costs, institutional overhead costs (capped at 28% per Pfizer policy), and indirect costs.
Pfizer Grants for Pediatric Pneumococcal Surveillance Studies Requirements
- The institution and Principal Investigator (PI) must be based in Saudi Arabia as noted above.
- Only organizations are eligible to receive grants. Multicenter collaboration is encouraged.
- Individuals or medical practice groups (i.e., an independent group of physicians not affiliated with a hospital, academic institution, or professional society) are not eligible to receive grants.
- If the project involves multiple departments within an institution and/or between different institutions / organizations / associations, all institutions must have a relevant role and the requesting organization must have a key role in the project.
- The PI must have a medical or postdoctoral degree (MD, PhD, or equivalent), an advanced nursing degree (BSN with a MS/PhD), or a degree in Pharmacy.
- The applicant must be the PI or an authorized designee of such individual (e.g., PI’s research coordinator).
- The PI must be an employee or contractor of the requesting organization.
- Requesting organization must be legally able to receive award funding directly from Pfizer International LLC. We strongly recommend that applicants confirm this with their organization or institution prior to submitting an application. Grants awarded to organizations that are subsequently found to be unable to accept funding directly from Pfizer International LLC may be subject to rescission.
Application Date and Process
- Click on the link to the application website to apply.
Application Deadline
01 June, 2026
Opportunity Application
View details of
Pfizer Grants for Pediatric Pneumococcal Surveillance Studies
Apply for Pfizer Grants for Pediatric Pneumococcal Surveillance Studies
🔍
